In 2023, Japan led global private non-profit expenditure on R&D in medical and health sciences, contributing significantly higher than other nations with a value of 38.3 million USD. South Korea followed with 26.43 million USD, showcasing robust growth, while Italy trailed closely with 23.69 million USD. Notably, Russia and the Czech Republic showed impressive year-on-year growth rates of 26.31% and 27.02% respectively, indicating a fierce commitment to enhancing their R&D capabilities. Conversely, countries like Slovakia and Israel experienced declines, hinting at potential challenges in maintaining or boosting their R&D investments.
Looking ahead, nations with positive growth trends, especially those with double-digit increases like South Korea, Russia, Poland, and the Czech Republic, are poised to further strengthen their positions in the global R&D landscape. Monitoring the strategic shifts and increased investment focus in these countries will be crucial to understanding the evolving dynamics in global R&D expenditures within the medical and health sciences sector.
Top countries in Private Non-Profit Expenditure on R&D in Medical and Health Sciences Share by Country (Million US Dollars PPP = 2015)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 38.3 | 2023 | +1.31% | +5.32% | View data |
| 2 | 2 South Korea | 26.43 | 2023 | +4.97% | +15.7% | View data |
| 3 | 3 Italy | 23.69 | 2023 | -0.38% | +4.76% | View data |
| 4 | 4 Canada | 2.99 | 2023 | -3.91% | +2.72% | View data |
| 5 | 5 Spain | 2.94 | 2023 | +2.25% | +3.43% | View data |
| 6 | 6 Finland | 1.91 | 2023 | +4.2% | +3.62% | View data |
| 7 | 7 Russia | 1.06 | 2023 | +6.17% | +26.31% | View data |
| 8 | 8 Portugal | 0.99 | 2023 | +5.23% | +5% | View data |
| 9 | 9 Chile | 0.78 | 2023 | -0.054% | -3.94% | View data |
| 10 | 10 Taiwan | 0.34 | 2023 | -9.78% | -5.14% | View data |
